Mice bearing the mutated gene for Cu/Zn superoxide dismutase (G93A) are a good model for human amyotrophic lateral sclerosis (ALS). They develop progressive limb paralysis paralleled by loss of motor neurons of the cervical and lumbar spinal cord, which starts at 3-3.5 months of age and ends with death at 4-5 months. Several treatments have been attempted to delay clinical symptoms and to extend lifespan, and some have had modest beneficial effects. One such treatment, based on long-term administration of valproic acid (VPA), resulted in controversial results. We report here that, while dietary supplementation with high VPA dosage slows down motor neuron death, as assessed by measurement of a specific marker for cholinergic neurons in the spinal cord, it has no significant effect on lifespan. Recently, the hypothesis has been put forward that a deficiency of retinoic acid (RA) and its signaling may have a role in ALS. We report that long-term dietary supplementation with RA has no effect on the decrease of the cholinergic marker in the spinal cord, but it significantly shortens lifespan of G93A mice.

Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model froamyotrophic lateral sclerosis / Crochemore C.; Virgili M.; Bonamassa B.; Canistro D.; Pena-Altamira E.; Paolini M.; Contestabile A.. - In: MUSCLE & NERVE. - ISSN 0148-639X. - STAMPA. - 39:(2009), pp. 548-552. [10.1002/mus.21260]

Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model froamyotrophic lateral sclerosis

CROCHEMORE, CHRISTOPHE;VIRGILI, MARCO;BONAMASSA, BARBARA;CANISTRO, DONATELLA;PENA ALTAMIRA, LUIS EMILIANO;PAOLINI, MORENO;CONTESTABILE, ANTONIO
2009

Abstract

Mice bearing the mutated gene for Cu/Zn superoxide dismutase (G93A) are a good model for human amyotrophic lateral sclerosis (ALS). They develop progressive limb paralysis paralleled by loss of motor neurons of the cervical and lumbar spinal cord, which starts at 3-3.5 months of age and ends with death at 4-5 months. Several treatments have been attempted to delay clinical symptoms and to extend lifespan, and some have had modest beneficial effects. One such treatment, based on long-term administration of valproic acid (VPA), resulted in controversial results. We report here that, while dietary supplementation with high VPA dosage slows down motor neuron death, as assessed by measurement of a specific marker for cholinergic neurons in the spinal cord, it has no significant effect on lifespan. Recently, the hypothesis has been put forward that a deficiency of retinoic acid (RA) and its signaling may have a role in ALS. We report that long-term dietary supplementation with RA has no effect on the decrease of the cholinergic marker in the spinal cord, but it significantly shortens lifespan of G93A mice.
2009
Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model froamyotrophic lateral sclerosis / Crochemore C.; Virgili M.; Bonamassa B.; Canistro D.; Pena-Altamira E.; Paolini M.; Contestabile A.. - In: MUSCLE & NERVE. - ISSN 0148-639X. - STAMPA. - 39:(2009), pp. 548-552. [10.1002/mus.21260]
Crochemore C.; Virgili M.; Bonamassa B.; Canistro D.; Pena-Altamira E.; Paolini M.; Contestabile A.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/84375
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 41
social impact